APA (7th ed.) Citation

Hamilton, J. D., Harel, S., Swanson, B. N., Brian, W., Chen, Z., Rice, M. S., . . . Graham, N. M. H. (2021). Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases. Clinical and experimental allergy, 51(7), 915-931. https://doi.org/10.1111/cea.13954

Chicago Style (17th ed.) Citation

Hamilton, Jennifer D., et al. "Dupilumab Suppresses Type 2 Inflammatory Biomarkers Across Multiple Atopic, Allergic Diseases." Clinical and Experimental Allergy 51, no. 7 (2021): 915-931. https://doi.org/10.1111/cea.13954.

MLA (9th ed.) Citation

Hamilton, Jennifer D., et al. "Dupilumab Suppresses Type 2 Inflammatory Biomarkers Across Multiple Atopic, Allergic Diseases." Clinical and Experimental Allergy, vol. 51, no. 7, 2021, pp. 915-931, https://doi.org/10.1111/cea.13954.